Recruiting Pancreatic Cancer Studies in Gilbert
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment....
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial ...
About Pancreatic Cancer Clinical Trials in Gilbert
Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.
There are currently 2 pancreatic cancer clinical trials recruiting participants in Gilbert, AZ. These studies are seeking a combined 816 participants. Research is being sponsored by Revolution Medicines, Inc., NRG Oncology. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pancreatic Cancer Clinical Trials in Gilbert — FAQ
Are there pancreatic cancer clinical trials in Gilbert?
Yes, there are 2 pancreatic cancer clinical trials currently recruiting in Gilbert, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Gilbert?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Gilbert research site will contact you about next steps.
Are clinical trials in Gilbert free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Gilbert studies also compensate for your time and travel.
What pancreatic cancer treatments are being tested?
The 2 active trials in Gilbert are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.
Data updated March 2, 2026 from ClinicalTrials.gov